Search

You searched for "neuroretinopathy"

550 results found

Innovations in posterior uveitis: In conversation with Dr Colin Chu

1 July 2025 | | EYE - Imaging
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...

Developments in retinal pigmentation measurement and the hopes of an equitable future

4 August 2025 | | EYE - Vitreo-Retinal, EYE - Imaging
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

MOSUK Annual Meeting 2026

25 February 2026
Medical Ophthalmological Society's 27th Annual Meeting

An elective in the land down under

2 April 2026 | | EYE - General
My clinical elective was spent at the Royal Victorian Eye and Ear Hospital (RVEEH) in Melbourne. As Australia’s only specialist tertiary hospital dedicated entirely to eye disease, RVEEH gave me significant exposure to, and enhanced my clinical understanding of, ophthalmology....

Beyond the slit lamp: Unanticipated lessons from my ophthalmology elective

3 April 2026 | | EYE - General
My six-week elective in ophthalmology at Westmead Hospital in Sydney offered much more than technical mastery; it challenged my assumptions about patient care, teaching and the role of curiosity in medicine. Though my passion for eyes was ignited by my...

The most memorable patient encounters and what they taught me

3 April 2026 | | EYE - General
In ophthalmology, some encounters blend quietly into the rhythm of clinic. Others stay with us, shaping how we practice and who we become as clinicians. These moments become the unexpected teachers of our training. They are subtle yet leave a...

Lessons from an unusual case of syphilis

3 August 2023 | | EYE - Vitreo-Retinal
The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

The invisible touch: a VISION 2020 LINK with Indonesia

1 February 2014 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Refractive, EYE - Pathology, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Indonesia’s population, the world’s fourth largest, is spread across 6,000 inhabited islands. Whilst some areas (e.g. Kalimantan, Papua) are relatively sparsely populated, Java is the world’s most densely populated island, with twice the population of the UK in half the...

IN FOCUS - The achievements and lasting effects of VISION 2020

1 April 2020 | | EYE - General
Blindness is a major public health problem globally. The first estimate of global blindness by the World Health Organization (WHO) in 1972 provided a figure of 10 to 15 million, which was considered an underestimate [1]. In 1999, an extraordinary...

Reflections on a twelve-year partnership: The Makassar-Dundee LINK

3 June 2021 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
In the first article of a two-part series (see Part 2 here), the authors provide an overview of this hugely successful partnership and how they overcame the challenges of COVID-19. What began in 2008 as a connection between equals, has...

More sensitive visual acuity test for age-related macular degeneration

1 October 2016 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...